HB710

2024 Regular Session

Other Sessions

House Committees

Senate Committees

Miscellaneous Committees

Scheduled Meetings

Representatives

Senators

Caucuses and Delegations

2018 Regular Session

HB710 by Representative Paul Hollis

DRUGS/PRESCRIPTION: Prohibits a manufacturer or wholesale distributor from engaging in unrestrained price increases in the sale of an essential off-patent or generic drug

Current Status: Pending House Health and Welfare - Sched. for 4/5/18

House Committee Amendment #2084 H&W Draft

Digest of HB710 Original

Paul Hollis (primary)

Date	Chamber	Journal Page	Action	sort history by ascending dates
03/21	H	3	Read by title, under the rules, referred to the Committee on Health and Welfare.
03/20	H	3	Read by title. Lies over under the rules.